GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases

JAMA Network Open 2026 Open access

Read full text
Authors: Kuan-Yu Chi, Yu Chang, Junmin Song, Chien‐Min Chen, Pang‐Shuo Perng, Hong-Min Lin
DOI: 10.1001/jamanetworkopen.2026.1311
Cited by: 2
References: 6

Abstract

This cohort study assesses the association between glucagon-like peptide–1 receptor agonist (GLP-1 RA) use and survival in patients with type 2 diabetes and brain metastases.

Fields of Study & Subjects

Diabetes Treatment and Management Metabolism Diabetes and Cancer Cancer Lipids and Metabolism

Publication details

Journal / source
JAMA Network Open
Publisher
American Medical Association (AMA)
Volume
9
Issue
3
Pages
e261311–e261311
Publication date
11 March 2026
Language
EN